AnaptysBio
ANAB
ANAB
113 hedge funds and large institutions have $675M invested in AnaptysBio in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
-5
Holders Change %
-4.24%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
35
Reduced
36
Closed
20
Calls
$1.47M
Puts
$1.34M
Net Calls
+$135K
Net Calls Change
+$64K
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$17.5M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
$21.2M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$3.47M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
$2.51M |
| 5 |
Goldman Sachs
New York
|
$4.04M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
VOYA Investment Management
Atlanta,
Georgia
| – | -$257K | -8,281 | Closed |
|
127
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$251K | -8,085 | Closed |
|
|
IFWM
128
Institute for Wealth Management
Denver,
Colorado
| – | -$250K | -8,055 | Closed |
|
|
FAM
129
Fred Alger Management
New York
| – | -$191K | -6,177 | Closed |
|
130
Allspring Global Investments
Charlotte,
North Carolina
| – | -$27.3K | -880 | Closed |
|